Back to search

Prevention of Heart Failure in Patients in the Heart Outcomes Prevention Evaluation (HOPE) Study

Data up to Jan 2025

Published2003
Citations225
References26

Total Citations Per Year

Abstract

References (26)

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

2000 • 8,612 citations

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

1999 • 8,588 citations

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

1991 • 8,296 citations

Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study

1997 • 7,096 citations

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction

1992 • 5,885 citations

Effects of Enalapril on Mortality in Severe Congestive Heart Failure

1987 • 4,763 citations

Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)

1988 • 3,818 citations

Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions

1992 • 3,708 citations

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy

2000 • 3,103 citations

Effect of Carvedilol on Survival in Severe Chronic Heart Failure

2001 • 3,011 citations

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

2000 • 2,991 citations

The epidemiology of heart failure: The Framingham Study

1993 • 2,278 citations

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

2000 • 2,085 citations

Survival after the onset of congestive heart failure in Framingham Heart Study subjects.

1993 • 1,852 citations

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure

1993 • 1,775 citations

A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction

1995 • 1,734 citations

Effect of carvedilol on survival in severe chronic heart failure

2001 • 1,630 citations

National Hospital Discharge Survey, 1988

1991 • 1,312 citations

Global Burden of Cardiovascular Diseases

2001 • 1,135 citations

Effects of Ramipril and Vitamin E on Atherosclerosis

2001 • 726 citations

Evidence of Improving Prognosis in Heart Failure

2000 • 565 citations

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.

1994 • 511 citations

Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995

1999 • 497 citations

Antiplatelet Agents and Survival: A Cohort Analysis From the Studies of Left Ventricular Dysfunction (SOLVD) Trial

1998 • 273 citations

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

1996 • 154 citations

Cardiac function and heart failure

2001 • 38 citations

Cited By (0)

Loading...